Darmstadt, Germany (ots/PRNewswire) - Not intended for UK based media - Detailed 26-week results of SPARK study presented at SSIEM Annual Symposium - Phenylalanine tolerance significantly increased in children with PKU below 4 years of age, previously shown to be responsive to Kuvan and treated with Kuvan plus a ...
Darmstadt, Germany (ots/PRNewswire) - - First patient begins treatment in an international Phase II study investigating the efficacy and safety of MSB0010718C in patients with metastatic Merkel cell carcinoma (mMCC) - mMCC is a rare and aggressive skin cancer lacking effective treatments - MSB0010718C is also ...
Darmstadt, Germany (ots/PRNewswire) - - FDA clearance validates Eeva System, which enables in-vitro fertilization (IVF) clinicians to offer the proprietary Eeva Test and further demonstrates commitment by Merck Serono and Auxogyn to bring innovative technologies to the IVF community - Eeva Test first-of-a-kind ...
Darmstadt, Germany (ots/PRNewswire) - - Development and commercialization agreement on blood-based RAS biomarker mutation status test for (metastatic) colorectal cancer (mCRC) - This non-invasive, fast and easy-to-perform diagnostic test is expected to provide a real-time reflection of a patient's RAS mutation status to help guide clinical decision making in mCRC Merck ...
Darmstadt, Germany (ots/PRNewswire) - ASCO abstract #: Anti-PD-L1: 3064; c-Met: 2521, TPS4151, TPS8121; tecemotide: TPS3658, TPS7608; TH-302: 8534, 2029; further pipeline: 3551, TPS9107, 5030, 2050, e13552 - Robust pipeline reflects commitment to innovation in oncology and immuno-oncology - Data from nine Merck ...
Darmstadt, Germany (ots/PRNewswire) - - For the 6th time in a row Merck Serono takes part in the International Thyroid Awareness Week with focus on HIGH FIVE - Five reasons to be aware of thyroid disease: Thyroid cancer, autoimmunity, infertility, anxiety/depression, and iodine deficiency Merck Serono, the biopharmaceutical division of Merck, together with Thyroid ...
Darmstadt, Germany (ots/PRNewswire) - ASCO Abstract Number: 3506 - In a retrospective analysis of the Phase III CRYSTAL* study, which assessed RAS tumor status, significant clinical benefit was observed in mCRC patients with RAS wild-type tumors receiving Erbitux plus FOLFIRI, compared with FOLFIRI alone - No ...
Darmstadt, Germany (ots/PRNewswire) - - Primary endpoint met in SPARK study: significant increase in phenylalanine tolerance demonstrated after 26 weeks of the study in children less than 4 years of age with phenylketonuria and responsive to Kuvan treated with Kuvan plus a phenylalanine-restricted diet, versus diet alone - SPARK study was conducted as a post-authorization measure and results will be submitted to EMA this ...
Hilden, Germany And Vienna (ots/PRNewswire) - - Reliable diagnostic tools under development for mutations of calreticulin (CALR) are expected to benefit patients with blood disorders known as myeloproliferative neoplasms - QIAGEN acquired exclusive worldwide license for CALR biomarker from CeMM Vienna, whose ...
Darmstadt, Germany (ots/PRNewswire) - - First patient dosed in tecemotide Phase III trial; study recruiting across 250 sites in over 20 countries - START2 builds upon the data from the START* trial and explores the potential of tecemotide in patients with Stage III NSCLC who have demonstrated stable disease or ...
Munich, Germany (ots/PRNewswire) - For European Media Only, Not for UK Media Atrial fibrillation (AF) is the most common heart rhythm disorder[1] resulting in a five-fold increased risk of stroke compared with the general population[2] Daiichi Sankyo today announced its commitment to extend the PREvention oF ...
Darmstadt, Germany (ots/PRNewswire) - - The multidisciplinary Oncology Partnership and Education Network (OPEN) aims to improve patient outcomes in oncology, with initial focus on metastatic colorectal cancer (mCRC) - OPEN aims to raise public awareness and understanding of the importance of biomarker testing in mCRC Merck Serono, the biopharmaceutical division of ...
Darmstadt, Germany (ots/PRNewswire) - - The ESPART* Phase III clinical study focuses on patients that respond poorly to attempts at ovarian stimulation - Study aims to recruit 946 patients across 17 European countries Merck, the global pharmaceutical and chemical company, today announced the enrollment of the first ...
Pullach, Germany (ots/PRNewswire) - As a globally leading healthcare company, Linde Healthcare is dedicated to research and innovative developments. The REALfund supports purposeful solutions within respiratory medicine that benefit patients and caregivers alike. For further information and to apply, visit the REALfund website at ...
Freiburg, Germany (ots/PRNewswire) - 99 percent of floor space is already booked Leading representatives of the international jewellery and gemstone industry has expressed the need for an appropriate and commercially focused jewellery sourcing platform in Europe. With the Jewellery & Gem Fair Europe, UBM has responded by providing such a platform, at the cross roads of the industry's most important hubs, such as Antwerp, ...
Darmstadt, Germany (ots/PRNewswire) - - The European Commission's approval is based on the CHMP positive opinion - Label update comes in response to new biomarker data obtained from the OPUS study Merck Serono, the biopharmaceutical division of Merck, today announced that the European Commission has approved the ...
Darmstadt, Germany (ots/PRNewswire) - - New agreement aims to translate CNIO research into new potential treatment options for cancer patients - License agreement encompasses two series of ATR inhibitors and a screening platform Merck Serono, the biopharmaceutical division of Merck, today announced that a license ...
Aachen, Germany / Redwood City (California), USA (ots) - Grünenthal Group today announced that the company entered into a commercial partnership with AcelRx Pharmaceuticals, Inc. for ZALVISO, a patient-controlled analgesia device for self- administration of sufentanil nanotablets by patients following surgery. The agreement covers the countries of the European Union, ...
Darmstadt, Germany (ots/PRNewswire) - - Publication offers detailed results of START, including an exploratory analysis of the clinically meaningful survival prolongation with tecemotide maintenance therapy in a predefined subgroup of patients treated with concurrent chemoradiotherapy - As previously announced Merck ...
Frankfurt Am Main, Germany (ots/PRNewswire) - Food ingredients Europe proved once again it's the world's leading food industry event. In Frankfurt from the 19-21 November the doors welcomed close to 25,000 attendees. And an outstanding 80% of visitors confirmed that they control the purse strings of some the world's ...
Frankfurt Am Main, Germany (ots/PRNewswire) - Roquette's innovative new Microalgae High Lipid Algal Flour has been recognised as the most innovative food ingredient of 2013. Successfully reducing fat and replacing eggs while providing sustainability, health, functionality and cost benefits to producers and consumers ...
Darmstadt, Germany (ots/PRNewswire) - - CHMP recommendation comes in response to new biomarker data obtained from the OPUS study Merck Serono, the biopharmaceutical division of Merck, today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a ...
Düsseldorf, Germany (ots/PRNewswire) - New healthcare solutions developed with users and patients help improve the recovery process and treatment options for patients while supporting medical staff in their work Healthcare is constantly changing. The best way to deal with this change is for all parties in the sector to join forces. Philips is putting this principle into action under the banner "Transforming healthcare, ...
Darmstadt, Germany (ots/PRNewswire) - - New agreement marks the second collaboration between Merck and BeiGene Merck Serono, the biopharmaceutical division of Merck, today announced that a global licensing, co-development, and commercialization agreement for BeiGene-290 has been signed with BeiGene Co., Ltd., a ...
Frankfurt, Germany (ots/PRNewswire) - API Corporation, E-Pharma Trento and Camurus- the 2013 winners The CPhI Pharma Awards 2013 winners were announced live at the awards ceremony- day one at CPhI Worldwide [http://www.cphi.com ]. Honouring outstanding developments from some key industry players, the awards highlighted ever-advancing market innovations, fundamental to driving growth throughout global pharma. (Logo: ...
Frankfurt, Germany (ots/PRNewswire) - CPhI expert industry panel members highlight future implications for pharma in final part of CPhI industry report Industry to encounter drug shortages and threat of adulterated products, with pharma shifting focus to orphan drug development, low cost products and continuous processing Report's expert highlights Girish Malhotra, ...
Frankfurt, Germany (ots/PRNewswire) - CPhI Expert Industry Panel Members Comment on Future Contingencies for Pharma in Part II of CPhI Industry Report Pharma to change business model to include increased academic partnerships, CMO development work, more niched products, industry-wide QbD and regulation of suppliers Report's expert highlights Sam Venugopal, Director, ...
Frankfurt, Germany (ots/PRNewswire) - Frankfurt IAA hosts Germany's first Supercharger Tesla Motors [http://www.teslamotors.com ] presents its award winning Model S and revolutionary Supercharger at this year's Internationale Automobil-Ausstellung (IAA) in Frankfurt. Having begun the first European deliveries of ...
Frankfurt, Germany (ots/PRNewswire) - Source innovative products, grow your market share and nurture your business network at the world's largest food ingredients show With the global food ingredients market forecasted to grow in 2013 by 2.7%, this industry is set to flourish and meet the requirements of the ever changing consumer trends. Given this development, as well as the population growth and the increasing ...
Munich, Germany (ots) - * Lack of patient adherence to hypertension treatment is one of the root causes of failure to reach blood pressure goals, contributing to increased risk of serious cardiovascular events * The Daiichi Sankyo myHypertensionCare patient support programme aims to improve patient engagement and ...